Harvard Bioscience, Inc. (HBIO)
5.10
-0.15
(-2.86%)
USD |
NASDAQ |
May 18, 12:45
Harvard Bioscience Total Liabilities (Quarterly) : 67.89M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 5.905B |
| Bio-Rad Laboratories, Inc. | 2.939B |
| Bruker Corp. | 3.628B |
| Azenta, Inc. | 349.21M |
| Revvity, Inc. | 4.814B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 77.94M |
| Shareholders Equity (Quarterly) | 10.05M |
| Debt to Equity Ratio | 4.392 |
| Current Ratio | 1.990 |
| Net Debt Paydown Yield | 0.34% |